Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications

Stopped early · Not applicable

Conditions studied: Cardiac Disease

In brief

The purpose of this study is to understand how simultaneous PET/MR acquisition can provide novel qualitative and quantitative biomarkers to guide clinical intervention and predict prognosis of patients with cardiovascular disease.

Key facts

Study ID

NCT02062008

Run by

University of California, San Francisco

People needed

2

Starts

2016-12-01

Expected to finish

2018-02-10

Last updated by the study team

2021-06-16

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with ischemic and non-ischemic cardiac disease referred for cardiac PET for viability imaging.

You may not qualify if…

• Contraindications for MRI, including cardiac pacemaker, claustrophobia, retained metallic foreign body, cochlear implant, Aneurysm clip in the brain, pregnancy and eGFR less than 45%.

Where it is running

• UCSF University of California in San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.